https://www.avient.com/knowledge-base/case-study/medical-hose-manufacturer-boosts-productivity-specialized-material?pname[]=10729
The Challenge
In the course of their research into material options, the manufacturer’s team invited Avient to suggest options for an alternative TPV based on its global reputation for superior products and service.
With Avient’s assistance and experience in medical device applications, the manufacturer immediately realized the following lifts:
https://www.avient.com/sites/default/files/2024-08/Avient Thermoplastic Composite Tapes Product Overview.pdf
Available in rolls of unidirectional
tape as well as X-Ply™ 0°/90° and other multi-ply
laminates, Polystrand materials can be post-
formed and co-molded with mixed materials in
thermoforming and injection molding processes
to provide lightweight strength to a variety of part
designs.
Avient makes no warranties or
guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
AVIENT MAKES NO WARRANTIES, EXPRESS
OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the
information.
https://www.avient.com/idea/exploring-benefits-bio-based-alternatives
This can be challenging for many companies as they strive to comply with regulations while managing product development, production efficiencies, and costs.
Learn more about Avient’s bio-based plastisol solutions or contact us for help with your application challenges.
Why Three-Party Collaboration Leads to Bottle Manufacturing Success
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/eccoh-low-smoke-and-fume-non-halogen-formulations
Important information about the health, safety and environmental impacts of Avient products.
Ideally suited for thin wall and blowing cable applications
ECCOH 5161 - OFC Blowing Application in Railways
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Goldman%2520Sachs%2520Conference%2520w%2520nonGAAP.pdf
Slide 1
PolyOne Corporation Page 1
PolyOne Investor Presentation
Goldman Sachs 2014 US Emerging / SMID
Cap Growth Conference
New York, NY
November 20, 2014
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
S&P 500
-150%
-50%
50%
150%
250%
350%
450%
550%
POL S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 YTD 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.9% 12 – 16%
Global Specialty Engineered
Materials 1.1% 12.1% 12 – 16%
Designed Structures & Solutions -- 7.6% 8 – 10%
Performance Products &
Solutions 5.5% 8.1% 9 – 12%
Distribution 2.6% 6.2% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 65% 65 – 75%
3) ROIC* 5.0% 10.6% 15%
4) Adjusted EPS Growth N/A 37% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
32% Adjusted EPS CAGR from 2011
2015 EPS: $2.50
2011 EPS: $0.82
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid Single Digit Revenue Growth
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
31%
2006 2013
Specialty Platform
Gross Margin %
20%
43%
2006 2013
Specialty Vitality Index Target ≥ 35%
Vitality Products
+ 700 to 1000 bps
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions) TBD TBD $800 $450 $450 $1,700
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of September 30, 2014
Debt Maturities & Pension Funding – 9/30/14
Net Debt / EBITDA* = 1.7x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of September 30, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 9/30/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.5 million shares in
Q3 2014
Repurchased 9.7 million
shares since early 2013
10.3 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/investor-center/investor-news/archives?page=28
CLEVELAND, July 10, 2017 /PRNewswire/ -- PolyOne Corporation (NYSE: POL) a premier provider of specialized polymer materials, services and solu
July 10, 2017
https://www.avient.com/investor-center/investor-news/archives?page=24
CLEVELAND, April 10, 2018 /PRNewswire/ -- PolyOne Corporation (NYSE: POL) a premier provider of specialized polymer materials, services and sol
April 10, 2018
https://www.avient.com/investor-center/investor-news/archives?page=16
CLEVELAND, Feb. 10, 2020 /PRNewswire/ -- The Board of Directors of PolyOne Corporation (NYSE: POL), has declared a quarterly cash dividend of t
February 10, 2020
https://www.avient.com/investor-center/investor-news/archives?page=32
CLEVELAND, Oct. 10, 2016 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solution
October 10, 2016
https://www.avient.com/investor-center/news/polyone-announces-appointment-woon-keat-moh-president-color-additives-and-inks
I look forward to helping our customers overcome their business challenges with our growing sustainable solutions portfolio and world-class service."